Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OBIO · against 340 other Healthcare companies of similar size
Ranked #10 of 341 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score35 peers with a growth score of 90–100, including OBIO · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | OBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 354 reported | 986.1% | 3.0% | 99% | 33% | |
| Earnings per share growthHigher is better · 163 reported | Not reported | 3.6% | — | — | 33% |
| 3-year revenue growthHigher is better · 332 reported | 94.5% | 3.7% | 94% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 10 | 500M USD | 96 | 63 | |
| 10 | 660M USD | 96 | 43 | |
| 10 | 598M USD | 96 | 49 | |
| 10 | 275M USD | 96 | 46 | |
| 10 | 334M USD | 96 | 49 | |
| 10 | 172M USD | 96 | 34 | |
| 18 | 4.7B CNY (≈$653M) | 95 | 52 | |
| 18 | 274M USD | 95 | 57 | |
| 18 | 467M USD | 95 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score